Hormona announces £1.2m fund to shine light on hormonal health

Hormona, a data-driven women’s health company targeting hormonal imbalances, has announced today their funding round of £1.2m from Nascent Invest AB, Techstars and Blackheat Capital AB.

The funding will mainly go towards growing the team and completing the test development in preparation for the launch in Europe this autumn and a future launch in the U.S in 2023.

Founded in 2020 by Swedish natives Karolina Lofqvist and Jasmine Tagesson, Hormona is the result of Karolina’s own personal struggle with hormone imbalance, the related symptoms and the huge problem that lies in receiving the correct diagnosis, care and access to information.

The two founders, currently based in LA, aim to establish Hormona on the American market, with the help of Techstars, one of the world’s leading accelerators that has invested in over 2000 companies since its inception.

“I’m incredible happy to announce that Hormona has closed £1.2m and that our app is now live in Sweden,” declared Karolina Lofqvist on her LinkedIn page.

“This is just the start of our journey of empowering women to live happier and healthier live in harmony in their hormones. Our hope is to save millions of women the cost and pain of going through the same journey as I did, and develop an affordable way for women to track and understand their hormones to allow easier transitions through the various stages of their life.”

The team behind Hormona have invented an at-home urine test that easily measures the three most important female hormones quantitatively in less than 15 minutes, completely removing the need for a lab and empowering women to understand and monitor their hormone levels regularly from the comfort of the home.

Through their test and software women no longer have to solely rely on the healthcare system to understand what is actually going on in their bodies on a daily basis. Through regular testing Hormona can help support women with issues such as irregular cycles, hormonal imbalance, PCOS, perimenopause, menopause and infertility.

By providing exact hormonal levels alongside logged symptoms, personalised explanations, tips and treatments options, the company wants every single woman to understand and manage her hormones with confidence.

In December 2021 Hormona won the prestigious Slush100 pitch competition, being also selected to present at Wired Health 2022 as part of the Wired Health EY Startup Showcase.

For more info, visit hormona.io.